Natural Biocon (India) Ltd
Natural Biocon (India) Ltd (NATURAL) last reported results for the quarter ended Jun 2026, with sales of ₹0 crore and net profit of ₹-0.01 crore. The stock last traded at ₹2.39, a market capitalisation of ₹6.16 crore. Over the past 52 weeks the stock has ranged between ₹2.39 and ₹6.49. Figures are as of 6 Oct 2026 and are not real time.
Natural Biocon (India) Ltd share price and key metrics
- Current price
- ₹2.39
- Market cap
- ₹6.16 cr
- Book value
- ₹11.9
- ROE
- -0.13%
- ROCE
- -0.13%
- Dividend yield
- 0.00%
- 52w high / low
- 6.49/2.39
Metrics as of 6 Oct 2026. Not real time.
Track Natural Biocon (India) Ltd
Cruxal reads every Natural Biocon (India) Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Natural Biocon (India) Ltd growth and returns
- 10 Years
- 48%
- 5 Years
- 81%
- 3 Years
- 27%
- TTM
- -90%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- -280%
- 10 Years
- %
- 5 Years
- -39%
- 3 Years
- -36%
- 1 Year
- -60%
- 10 Years
- 1%
- 5 Years
- 0%
- 3 Years
- 0%
- Last Year
- 0%
Natural Biocon (India) Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹0 cr, down 100.0% from ₹1.67 cr a year earlier. Net profit swung to a loss of ₹0.01 cr.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 4.74 | 1.28 | 1.35 | 1.67 | 0 | 0 | 0.88 | 0 |
| Expenses | 4.54 | 1.03 | 1.84 | 1.53 | 0.04 | 0.04 | 0.97 | 0.01 |
| Operating profit | 0.2 | 0.25 | -0.49 | 0.14 | -0.04 | -0.04 | -0.09 | -0.01 |
| OPM % | 4.22% | 19.53% | -36.30% | 8.38% | — | — | -10.23% | — |
| Other income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0.2 | 0.25 | -0.49 | 0.14 | -0.04 | -0.04 | -0.09 | -0.01 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net profit | 0.2 | 0.25 | -0.49 | 0.14 | -0.04 | -0.04 | -0.09 | -0.01 |
| EPS (₹) | 0.08 | 0.10 | -0.19 | 0.05 | -0.02 | -0.02 | -0.03 | -0.00 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Natural Biocon (India) Ltd annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.15 | 1.04 | 0.45 | 0 | 0.13 | 0.48 | 1.25 | 13.53 | 8.35 | 2.55 | 0.88 |
| Operating profit | 0.11 | 1 | 0.11 | -0.03 | 0 | 0.09 | 0.25 | 0.23 | 0.06 | -0.04 | -0.18 |
| OPM % | 73.33% | 96.15% | 24.44% | — | 0.00% | 18.75% | 20.00% | 1.70% | 0.72% | -1.57% | -20.45% |
| Net profit | 0.08 | 0.7 | 0.07 | -0.08 | 0 | 0.07 | 0.18 | 0.15 | 0.04 | -0.04 | -0.18 |
| EPS (₹) | 0.07 | 0.62 | 0.06 | -0.07 | 0.00 | 0.06 | 0.16 | 0.13 | 0.02 | -0.02 | -0.07 |
TTM is the trailing twelve months to the most recent quarter.
Natural Biocon (India) Ltd balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 11.37 | 11.37 | 11.37 | 11.37 | 11.37 | 11.37 | 11.37 | 11.37 | 25.78 | 25.78 |
| Reserves | 0.01 | 0.64 | 0.64 | 0.61 | 0.61 | 0.68 | 0.86 | 1.01 | 6.09 | 4.95 |
| Borrowings | 0.00 | 0.00 | 0.82 | 0.68 | 0.36 | 0.16 | 0.15 | 0.07 | 0.28 | 0.38 |
| Other liabilities | 0.13 | 0.42 | 0.19 | 0.05 | 0.04 | 0.08 | 1.13 | 4.32 | 6.37 | 5.73 |
| Total liabilities | 11.51 | 12.43 | 13.02 | 12.71 | 12.38 | 12.29 | 13.51 | 16.77 | 38.52 | 36.84 |
| Fixed assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 |
| CWIP | 3.29 | 3.29 | 3.29 | 3.29 | 3.29 | 3.29 | 3.29 | 3.29 | 3.29 | 3.29 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 21.12 | 21.12 |
| Other assets | 8.22 | 9.14 | 9.73 | 9.42 | 9.09 | 8.99 | 10.21 | 13.47 | 14.11 | 12.42 |
| Total assets | 11.51 | 12.43 | 13.02 | 12.71 | 12.38 | 12.29 | 13.51 | 16.77 | 38.52 | 36.84 |
As reported by the company. Total assets equal total liabilities by construction.
Natural Biocon (India) Ltd cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 0.21 | -0.04 | -0.86 | 0.15 | 0.32 | 0.18 | 0.21 | -0.12 | 1.30 | 0.03 |
| Cash from investing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 | -21.11 | -0.13 |
| Cash from financing | -0.07 | -0.07 | 0.75 | -0.14 | -0.32 | 0.00 | -0.02 | -0.09 | 19.67 | 0.09 |
| Net cash flow | 0.15 | -0.11 | -0.11 | 0.01 | 0.00 | 0.17 | 0.19 | -0.21 | -0.14 | -0.01 |
| Free cash flow | 0.21 | -0.04 | -0.86 | 0.15 | 0.32 | 0.17 | 0.21 | -0.12 | 1.30 | 0.01 |
| CFO / operating profit | 218% | 26% | -736% | -500% | — | 222% | 112% | -22% | 2,200% | -75% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Natural Biocon (India) Ltd operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 0.97% | 8.55% | 0.97% | -0.24% | 0.00% | 0.73% | 2.03% | 1.85% | 0.27% | -0.13% |
| Debtor days | 0.00 | 357.98 | 632.67 | — | 1,460.00 | 372.60 | 183.96 | 131.38 | 247.41 | 735.73 |
| Inventory days | 547.50 | — | — | — | — | — | 381.59 | 4.61 | 8.40 | 0.00 |
| Days payable | 0.00 | — | — | — | — | — | 423.07 | 117.92 | 270.17 | — |
| Cash conversion cycle | 547.50 | 357.98 | 632.67 | — | 1,460.00 | 372.60 | 142.48 | 18.07 | -14.36 | 735.73 |
| Working capital days | 2,238.67 | 572.07 | 681.33 | — | 3,818.46 | 357.40 | 134.32 | 49.10 | 14.86 | -131.69 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Natural Biocon (India) Ltd shareholding pattern
Promoters held 9.36% at Jun 2026, broadly unchanged since Jun 2025.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 9.36% | 9.36% | 9.36% | 9.36% | 9.36% | 9.36% | 9.36% | 9.36% |
| Public | 90.64% | 90.64% | 90.64% | 90.64% | 90.63% | 90.64% | 90.64% | 90.65% |
| No. of shareholders | 8,503 | 9,097 | 9,097 | 8,737 | 9,541 | 10,166 | 11,027 | 11,352 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Natural Biocon (India) Ltd corporate filings
- Natural Biocon (India) Limited announces resignation of MD and Company Secretary, with no immediate financial impact disclosedOtherslow impact
Cruxal's analysis: Natural Biocon (India) Limited has reported the resignation of its Managing Director, Mr…
Read the full analysis - Natural Biocon (India) Limited Announces Resignation of Managing Director Arun Kumar Dashrathbhai PrajapatiCompany Updatemedium impact
Cruxal's analysis: Natural Biocon (India) Limited has formally announced the resignation of its Managing…
Read the full analysis - Natural Biocon (India) Limited announces resignation of Company Secretary and Compliance OfficerCompany Updatelow impact
Cruxal's analysis: Natural Biocon (India) Limited has formally notified the exchange regarding the…
Read the full analysis - Natural Biocon (India) Limited Announces Significant Board Restructuring with Multiple Appointments and ResignationsOtherslow impact
Cruxal's analysis: Natural Biocon (India) Limited has undergone a major board-level transition, with the…
Read the full analysis - Natural Biocon (India) Limited Announces Board Appointments and Resignation of Company SecretaryBoard Meetinglow impact
Cruxal's analysis: Natural Biocon (India) Limited has announced the appointment of Mrs. Tapasya Sheth and…
Read the full analysis - Natural Biocon (India) Limited schedules Board Meeting for September 5, 2026, to approve annual reports and AGM logisticsBoard Meetinglow impact
Cruxal's analysis: Natural Biocon (India) Limited has issued a formal intimation regarding a Board Meeting…
Read the full analysis - Natural Biocon reports nil revenue for Q1 FY2027; announces change in statutory auditorsBoard Meetingmedium impact
Cruxal's analysis: Natural Biocon (India) Limited reported nil revenue from operations for the quarter ended…
Read the full analysis - Natural Biocon (India) Limited schedules board meeting for Q1 FY2027 results and auditor changeBoard Meetinglow impact
Cruxal's analysis: Natural Biocon (India) Limited has announced a board meeting scheduled for August 14…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.